6/20/25 16:08  | 6/18/25  | NKTX | Nkarta, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | CA | DO | CEO | S | -3 | 1.79 | 0 | -2 | -1 | 320 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/17/25 17:35  | 1/15/25  | NKTX | Nkarta, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | CA | DO | CEO | S | -38 | 2.20 | 0 | -17 | -5 | 320 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/20/24 17:03  | 6/18/24  | NKTX | Nkarta, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | CA | DO | CEO | S | -10 | 5.60 | 0 | -2 | -1 | 241 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/13/24 18:13  | 6/13/24  | PCRX | Pacira Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | FL | D |  | S.d | -25 | 28.38 | 0 | -1 | -6 | 13 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/18/24 16:40  | 1/16/24  | NKTX | Nkarta, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | CA | DO | CEO | S | -85 | 8.74 | 0 | -10 | -2 | 391 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/22/23 16:20  | 6/20/23  | NKTX | Nkarta, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | CA | DO | CEO | S | -8 | 4.85 | 0 | -2 | -1 | 313 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/7/23 21:23  | 6/5/23  | PCRX | Pacira Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | FL | D |  | S | -22 | 38.34 | 0 | -1 | -8 | 7 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/17/23 16:07  | 5/15/23  | PCRX | Pacira Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | FL | D |  | M.d | 209 | 29.90 | 0 | 7 | 999% | 7 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/17/23 16:07  | 5/15/23  | PCRX | Pacira Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | FL | D |  | S.d | -293 | 41.85 | 0 | -7 | -49 | 7 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/18/23 19:04  | 1/17/23  | NKTX | Nkarta, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | CA | DO | CEO | S.d | -20 | 5.49 | 0 | -4 | -1 | 313 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
9/30/22 16:30  | 9/28/22  | NKTX | Nkarta, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | CA | DO | CEO | S.m | -311 | 13.03 | 0 | -24 | -9 | 250 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
9/22/22 17:32  | 9/21/22  | NKTX | Nkarta, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | CA | DO | CEO | S | -80 | 13.01 | 0 | -6 | -2 | 274 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/13/22 16:03  | 7/11/22  | PCRX | Pacira Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | FL | D |  | S | -30 | 56.95 | 0 | -1 | -7 | 7 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/1/21 16:35  | 9/29/21  | NKTX | Nkarta, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | CA | DO | CEO | S | -231 | 27.18 | 0 | -9 | -4 | 219 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/23/21 16:05  | 6/21/21  | NKTX | Nkarta, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | CA | DO | CEO | S | -226 | 26.61 | 0 | -9 | -4 | 228 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/8/21 16:13  | 6/4/21  | PCRX | Pacira Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | NJ | D |  | S | -39 | 62.19 | 0 | -1 | -10 | 5 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/1/21 06:15  | 3/30/21  | NKTX | Nkarta, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | CA | DO | CEO | S | -523 | 30.74 | 0 | -17 | -7 | 236 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/9/21 16:12  | 3/5/21  | PCRX | Pacira Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | NJ | D |  | M.d | 42 | 13.98 | 0 | 3 | 96 | 6 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/9/21 16:12  | 3/5/21  | PCRX | Pacira Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | NJ | D |  | S.d | -198 | 65.88 | 0 | -3 | -33 | 6 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/8/20 21:05  | 6/4/20  | PCRX | Pacira Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | NJ | D |  | S | -96 | 47.46 | 0 | -2 | -29 | 5 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/6/19 16:39  | 6/4/19  | PCRX | Pacira Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | NJ | D |  | S.d | -33 | 42.66 | 0 | -1 | -10 | 7 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/6/18 20:07  | 6/4/18  | PCRX | Pacira Pharmaceuticals, Inc. |  | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | NJ | D |  | S | -26 | 33.90 | 0 | -1 | -22 | 3 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/12/17 18:35  | 10/10/17  | OMED | Oncomed Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | CA | O | CB,CEO | S | -6 | 4.24 | 0 | -1 | 0 | 401 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/24/17 20:30  | 8/22/17  | PCRX | Pacira Pharmaceuticals, Inc. |  | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | NJ | D |  | S | -38 | 36.15 | 0 | -1 | -23 | 4 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/5/17 19:38  | 4/4/17  | OMED | Oncomed Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | CA | DO | CB,CEO | S | -59 | 9.06 | 2 | -6 | -2 | 357 | D | -64 | -15 | -23 | 17 | 1 | -13 | -3 | -4 | 3 | -41 | -56 |  |  |  | 
1/9/17 17:55  | 1/5/17  | OMED | Oncomed Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | CA | DO | CB,CEO | M.dm | 61 | 1.43 | 1 | 43 | 13 | 362 | D | -66 | -60 | -33 | -23 | -10 | 10 | 11 | 13 | 1 | -8 | -9 | 1 |  |  | 
1/9/17 17:55  | 1/5/17  | OMED | Oncomed Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | CA | DO | CB,CEO | S.dm | -357 | 8.34 | 1 | -43 | -11 | 362 | D | -66 | -60 | -33 | -23 | -10 | 10 | 11 | 13 | 1 | -8 | -9 | 1 |  |  | 
6/8/16 19:02  | 6/6/16  | PCRX | Pacira Pharmaceuticals, Inc. |  | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | NJ | D |  | S | -53 | 46.95 | 33 | -1 | -40 | 2 | D | -42 | -39 | -25 | -4 | -20 | 9 | 10 | 0 | -3 | -10 | -23 | -13 | -34 |  | 
6/8/16 17:18  | 6/7/16  | RLYP | Relypsa Inc |  | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | CA | D |  | S | -20 | 19.32 | 33 | -1 | -29 | 2 | D | -21 | -46 | -34 | 43 | 5 | 32 | 17 | -7 | -2 | 1 | 2 |  |  |  | 
2/22/16 19:38  | 2/17/16  | PCRX | Pacira Pharmaceuticals, Inc. |  | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | NJ | D |  | M.d | 39 | 12.92 | 33 | 3 |  | 3 | D | -13 | -47 | -4 | 9 | -9 | 3 | 6 | 3 | -4 | -12 | -25 | -33 | -33 | -32 | 
2/22/16 19:38  | 2/17/16  | PCRX | Pacira Pharmaceuticals, Inc. |  | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | NJ | D |  | S.d | -180 | 60.00 | 33 | -3 | -51 | 3 | D | -13 | -47 | -4 | 9 | -9 | 3 | 6 | 3 | -4 | -12 | -25 | -33 | -33 | -32 | 
1/8/16 19:25  | 1/6/16  | OMED | Oncomed Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | CA | DO | CB,CEO | S | -54 | 22.28 | 3 | -2 | -1 | 347 | D | -30 | -15 | 10 | 19 | -3 | 4 | -1 | 0 | -15 | -21 | -52 | -46 | -35 | -54 | 
11/24/15 18:32  | 11/20/15  | PCRX | Pacira Pharmaceuticals, Inc. |  | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | NJ | D |  | M.d | 32 | 10.81 | 33 | 3 |  | 3 | D | 15 | -31 | -21 | 8 | 66 | 11 | 14 | 6 | 6 | 9 | 28 | -6 | -29 | -44 | 
11/24/15 18:32  | 11/20/15  | PCRX | Pacira Pharmaceuticals, Inc. |  | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | NJ | D |  | S.d | -180 | 60.00 | 33 | -3 | -51 | 3 | D | 15 | -31 | -21 | 8 | 66 | 11 | 14 | 6 | 6 | 9 | 28 | -6 | -29 | -44 | 
8/19/15 20:26  | 8/17/15  | PCRX | Pacira Pharmaceuticals, Inc. |  | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | NJ | D |  | M.d | 32 | 10.81 | 33 | 3 |  | 3 | D | 72 | -41 | -46 | -21 | -6 | 6 | -4 | 1 | -7 | -11 | 7 | -13 | -6 | -33 | 
8/19/15 20:26  | 8/17/15  | PCRX | Pacira Pharmaceuticals, Inc. |  | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | NJ | D |  | S.d | -180 | 60.02 | 33 | -3 | -51 | 3 | D | 72 | -41 | -46 | -21 | -6 | 6 | -4 | 1 | -7 | -11 | 7 | -13 | -6 | -33 | 
6/15/15 18:41  | 6/11/15  | RLYP | Relypsa Inc |  | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | CA | D |  | S | -50 | 34.63 | 13 | -1 | -29 | 4 | D |  | 44 | 7 | -16 | 12 | -1 | -4 | -3 | 0 | -1 | -6 | -28 | -18 | -43 | 
4/14/15 18:50  | 4/10/15  | PCRX | Pacira Pharmaceuticals, Inc. |  | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | NJ | D |  | M.d | 35 | 13.98 | 33 | 3 |  | 1 | D | 205 | 33 | -7 | -5 | -3 | -6 | 4 | 0 | 3 | -6 | -16 | -25 | -53 | -32 | 
4/14/15 18:50  | 4/10/15  | PCRX | Pacira Pharmaceuticals, Inc. |  | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | NJ | D |  | S.d | -220 | 88.00 | 33 | -3 | -75 | 1 | D | 205 | 33 | -7 | -5 | -3 | -6 | 4 | 0 | 3 | -6 | -16 | -25 | -53 | -32 | 
1/14/15 16:12  | 1/12/15  | PCRX | Pacira Pharmaceuticals, Inc. |  | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | NJ | D |  | M.d | 35 | 13.98 | 33 | 3 |  | 1 | D | 403 | 51 | 11 | 2 | 6 | 1 | 5 | 5 | -4 | 1 | 17 | -6 | -33 | -39 | 
1/14/15 16:12  | 1/12/15  | PCRX | Pacira Pharmaceuticals, Inc. |  | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | NJ | D |  | S.d | -235 | 94.06 | 33 | -3 | -75 | 1 | D | 403 | 51 | 11 | 2 | 6 | 1 | 5 | 5 | -4 | 1 | 17 | -6 | -33 | -39 | 
10/30/14 19:27  | 10/28/14  | OMED | Oncomed Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | CA | DO | CB,CEO | M.dm | 24 | 1.43 | 3 | 17 | 5 | 348 | D |  | 50 | -21 | 2 | 22 | 21 | 14 | 4 | -6 | -11 | -1 | 3 | 7 | -2 | 
10/30/14 19:27  | 10/28/14  | OMED | Oncomed Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | CA | DO | CB,CEO | S.dm | -369 | 21.99 | 3 | -17 | -5 | 348 | D |  | 50 | -21 | 2 | 22 | 21 | 14 | 4 | -6 | -11 | -1 | 3 | 7 | -2 | 
10/14/14 20:24  | 10/10/14  | PCRX | Pacira Pharmaceuticals, Inc. |  | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | NJ | D |  | M.d | 35 | 13.98 | 33 | 3 |  | 1 | D | 422 | 77 | 47 | 9 | -13 | -7 | -3 | -7 | 4 | 0 | -13 | -3 | -7 | -66 | 
10/14/14 20:24  | 10/10/14  | PCRX | Pacira Pharmaceuticals, Inc. |  | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | NJ | D |  | S.d | -237 | 94.87 | 33 | -3 | -75 | 1 | D | 422 | 77 | 47 | 9 | -13 | -7 | -3 | -7 | 4 | 0 | -13 | -3 | -7 | -66 | 
7/30/14 19:53  | 7/28/14  | OMED | Oncomed Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | CA | DO | CB,CEO | M.dm | 24 | 1.43 | 2 | 17 | 5 | 347 | D |  | 9 | -31 | -12 | -8 | 11 | 5 | -2 | -5 | -6 | -14 | -4 | 0 | -9 | 
7/30/14 19:53  | 7/28/14  | OMED | Oncomed Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | CA | DO | CB,CEO | S.dm | -371 | 22.11 | 2 | -17 | -5 | 347 | D |  | 9 | -31 | -12 | -8 | 11 | 5 | -2 | -5 | -6 | -14 | -4 | 0 | -9 | 
7/11/14 20:26  | 7/10/14  | PCRX | Pacira Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | NJ | D |  | M.d | 35 | 13.98 | 33 | 3 |  | 1 | D | 439 | 184 | 42 | 17 | 9 | -1 | -7 | -4 | 2 | -4 | 17 | 17 | 6 | -22 | 
7/11/14 20:26  | 7/10/14  | PCRX | Pacira Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | NJ | D |  | S.d | -211 | 84.41 | 33 | -3 | -75 | 1 | D | 439 | 184 | 42 | 17 | 9 | -1 | -7 | -4 | 2 | -4 | 17 | 17 | 6 | -22 | 
5/17/13 18:02  | 5/15/13  | PCRX | Pacira Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hastings Paul J | CA | D |  | P | 25 | 29.30 | 11 | 1 | New | 1 | D | 184 | 172 | 80 | 48 | 3 | 4 | 8 | 0 | -3 | 1 | 1 | 23 | 86 | 157 | 
4/29/05 15:47  | 4/29/05  | QLTI | Qlt Inc/bc | A1 | Health | Drug | Pharmaceutical Preparations | Hastings Paul J |  | DO | P,CEO | P | 10 | 10.77 | 11 | 1 | 10 | 10 | D | -10 | -61 | -36 | -34 | -20 | -15 | -6 | -4 | 1 | 7 | -2 | -18 | -37 | -22 |